AG
ORGS

Advisor Group’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Advisor Group’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-210
Closed -$9K – 5477
2019
Q3 		$9K Hold
210
– – ﹤0.01% 4416
2019
Q2 		$9K Buy
210
+100
+91% +$4.51K ﹤0.01% 4441
2019
Q1 		$6K Hold
110
– – ﹤0.01% 4614
2018
Q4 		$5K Buy
+110
New +$6.32K ﹤0.01% 4546

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.25B AUM 19.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TFGT
TS Financial Group (TSFG) Lake Forest, Illinois $794M AUM 24.65% 1-Year Est. Return

Advisor Group's ORGS Position: Q4 2019 in Review

Advisor Group sold out of Orgenesis Inc. Common Stock (ORGS) in Q4 2019, closing a stake of 210 shares — an estimated $9K sold.

Advisor Group first reported a position in ORGS in Q4 2018 and held it in 4 quarters. The position peaked at $9K in Q3 2019. 14 funds tracked by Wall St. Rank hold ORGS as of Q4 2019.

  • Advisor Group reported no remaining Orgenesis Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Advisor Group sold 210 Orgenesis Inc. Common Stock shares in Q4 2019, an estimated $9K.
  • Advisor Group first reported a position in Orgenesis Inc. Common Stock in Q4 2018 and held it in 4 quarters.
  • Advisor Group's Orgenesis Inc. Common Stock position peaked at $9K in Q3 2019.
  • 14 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.